Chemotherapy combined with anti-cancer agent shows promise for treatment of aggressiv
Some of the most aggressive forms of breast cancer are more vulnerable to chemotherapy when it is combined with a new class of anti-cancer agent, researchers from the Walter and Eliza Hall Institute have shown.